Literature DB >> 22537445

Is hepatitis virus resistance to antiviral drugs a threat?

Jean-Michel Pawlotsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22537445     DOI： 10.1053/j.gastro.2011.12.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

Review 1.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

2.  Molecular docking investigation of the binding interactions of macrocyclic inhibitors with HCV NS3 protease and its mutants (R155K, D168A and A156V).

Authors:  Ahmed A Ezat; Nihal S El-Bialy; Hamdy I A Mostafa; Medhat A Ibrahim
Journal:  Protein J       Date:  2014-02       Impact factor: 2.371

Review 3.  Management of Antiviral Resistance in Chronic Hepatitis B.

Authors:  Young-Suk Lim
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.